SGA
CLVS

Sector Gamma AS’s Clovis Oncology, Inc. CLVS Stock Holding History

Sector Gamma AS’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-156,969
Closed -$915K – 31
2020
Q3 		$915K Sell
156,969
-196,116
-56% -$1.17M 0.21% 28
2020
Q2 		$2.38M Sell
353,085
-23,000
-6% -$174K 0.49% 32
2020
Q1 		$2.39M Sell
376,085
-32,540
-8% -$261K 0.51% 30
2019
Q4 		$4.26M Sell
408,625
-22,800
-5% -$166K 0.68% 32
2019
Q3 		$1.7M Hold
431,425
– – 0.29% 34
2019
Q2 		$6.42M Buy
431,425
+51,648
+14% +$933K 1.03% 27
2019
Q1 		$9.43M Buy
379,777
+44,200
+13% +$1.11M 1.51% 21
2018
Q4 		$6.03M Buy
335,577
+150,000
+81% +$3.06M 1.01% 26
2018
Q3 		$5.45M Buy
185,577
+11,685
+7% +$452K 0.85% 25
2018
Q2 		$7.91M Buy
173,892
+50,000
+40% +$2.43M 1.31% 22
2018
Q1 		$6.54M Sell
123,892
-27,100
-18% -$1.58M 1.18% 25
2017
Q4 		$10.3M Buy
150,992
+2,900
+2% +$203K 1.73% 22
2017
Q3 		$12.2M Buy
+148,092
New +$11.7M 1.86% 18

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sector Gamma AS's CLVS Position: Q4 2020 in Review

Sector Gamma AS sold out of Clovis Oncology, Inc. (CLVS) in Q4 2020, closing a stake of 156,969 shares — an estimated $915K sold.

Sector Gamma AS first reported a position in CLVS in Q3 2017 and held it in 13 quarters. The position peaked at $12.2M in Q3 2017. 159 funds tracked by Wall St. Rank hold CLVS as of Q4 2020.

  • Sector Gamma AS reported no remaining Clovis Oncology, Inc. position as of Q4 2020 after selling out during the quarter.
  • Sector Gamma AS sold 156,969 Clovis Oncology, Inc. shares in Q4 2020, an estimated $915K.
  • Sector Gamma AS first reported a position in Clovis Oncology, Inc. in Q3 2017 and held it in 13 quarters.
  • Sector Gamma AS's Clovis Oncology, Inc. position peaked at $12.2M in Q3 2017.
  • 159 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2020.

Based on Sector Gamma AS's 13F filing for Q4 2020, filed 10 Feb 2021.